News & Analysis as of

Health Intellectual Property Business Organization

Read need-to-know updates, commentary, and analysis on Health issues written by leading professionals.

The Life Sciences Report - Summer 2017

Factoring in Human Factors - According to a recent British Medical Journal research report, the mean rate of death from medical error in U.S. hospitals is estimated to be over 251,000 people per year. Though many medical...more

TechConnect - Your Law Firm Link to Industry News - March 2017

by Mintz Levin on

Happy spring! This issue includes two articles that challenge conventional thinking. The first, called “Software is Still Patent Eligible,” makes the case that software patents can still be obtained. IP generally accretes in...more

Top 5 Patent Red Flags in Life Sciences Due Diligence

by JD Supra Perspectives on

Since IP represents 75 to 90% of the value of life science transactions, due diligence is a critical component of the valuation process....more

The Life Sciences Report - Winter 2017

Consumer Digital Health: Market Shift Is Leading to New Opportunities - The newest wave of consumer digital health investment focuses on applications encouraging consumers to change health-related behaviors, shifting...more

GSK and Verily Partnering to Form New Bioelectronic Medicine Firm

GlaxoSmithKline (GSK) announced that it is partnering with Verily Life Sciences LLC to form Galvani Bioelectronics. According to the press release, GSK and Verily will contribute IP rights and an investment of $712.7 million...more

Intellectual Property in Medicine: Tailoring your Patent Strategy

by Davis Brown Law Firm on

In last week’s post, we covered initial considerations for physicians considering patent protection. At this point, you may be wondering why we haven’t talked about the actual patent application process. That’s because it...more

BakerHostetler Data Security Incident Response Report Shows Human Error is More Often to Blame

by BakerHostetler on

Human error was the number one cause of data security incidents according to a new report released today by the Privacy and Data Protection Team at BakerHostetler. In the incidents that the firm worked on last year, employee...more

How is Graphene Currently Used and What is the Hope for the Future? [Video]

by Fenwick & West LLP on

In the second video of a three-part series, Fenwick attorney Paul Smith talks about the growing anticipation surrounding this strong, conductive and flexible material. Why the excitement? Simply put, graphene is easy. It’s...more

What is Graphene? Fenwick Patent Attorney Has the Answer [Video]

by Fenwick & West LLP on

The technology and life sciences communities alike have been raving about new "wonder material" graphene for the past year. From applications for wearable devices to the creation of lightweight, bendable televisions and...more

Two Tips for Inventors Filing Patent Applications [Video]

by Fenwick & West LLP on

The intense patent activity in graphene stems from its enormous technological and commercial potential. But because much of the territory underlying the graphene cross-roads has already been claimed, patenting graphene poses...more

Harvard Medical School Revises Conflicts of Interest Policy for Faculty Relationships with Industry

by William Fabbri on

The life science industry has had a long and mutually rewarding relationship with Harvard Medical School (HMS). HMS faculty members have founded life science companies, served as advisors and directors to life science...more

Creative Royalty Structures for Life Science Companies

by William Fabbri on

In any major license or partnering transaction, rarely is the royalty as simple as a single percentage on all net sales. The royalty provisions will include structures such as tier royalties, sublicense royalties, know-how...more

Joint Ownership: Shortcut to Trouble?

by William Fabbri on

Life science companies are constantly entering into collaborations or other agreements with third parties in which new intellectual property may be created, whether it is a full-fledged partnership with a large pharmaceutical...more

Patent Opposition in India: Recent Trends

by Rahul Dev on

Therefore, as may be seen, the two-stage patent opposition process has particularly affected the pharmaceutical industry, as the patent applicants are now vulnerable to multiple pre-grant oppositions filed by competitors, or...more

Importance of Patents for Start-ups, specially in Biotech

by Rahul Dev on

A patent is one of the ways by which technological innovations are protected. The most ironical fact about a patent is that although it gives monopoly for a number of years, but in order to gain the monopoly, the invention...more

Importance of Patents for Start-ups, specially in Biotech

by Rahul Dev on

A patent is one of the ways by which technological innovations are protected. The most ironical fact about a patent is that although it gives monopoly for a number of years, but in order to gain the monopoly, the invention...more

Antitrust and Trade Regulation Briefing By Robert K. Taylor

IN THIS ISSUE: *HIGHLIGHT ..U.S. Supreme Court Addresses Manufacturer Price Discrimination *RECENT DEVELOPMENTS ..Joint Venture Pricing Scrutinized ..Supreme Court Rules on Patent Tying ..Drug Companies Sued Over...more

17 Results
|
View per page
Page: of 1
Cybersecurity

Follow Health Updates on:

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.

Feedback? Tell us what you think of the new jdsupra.com!